AMY BOONE: Open Payments
NPI 1740467281 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,298 in 113 payments from 23 companies in 2025. Trend: 2023 $1,468 · 2024 $1,403 · 2025 $2,298
Food & beverage: $2,221Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $629 |
| Janssen Biotech, Inc. | 25 | $340 |
| Ardelyx, Inc. | 11 | $246 |
| QOL Medical, LLC | 7 | $220 |
| Madrigal Pharmaceuticals | 5 | $127 |
| Gilead Sciences, Inc. | 5 | $120 |
| Braintree Laboratories, Inc. | 5 | $114 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $49 |
| NeurAxis, Inc. | 1 | $47 |
Products named: TREMFYA, IBSRELA, RINVOQ, Sucraid, LINZESS, REZDIFFRA, SKYRIZI, SUTAB.
Industry payments across SC — which companies pay providers there.
